Advanced Oncotherapy – The Times of India (Kolkata) – Personalized cancer treatment on way

Experts See A Future In Proton Therapy, Feel Research Is Helping Categorize Patients.  Treatment of cancer will gradually move towards personalized medicines, said experts. According to oncologist Peter Hoskin, with the advancement in cancer research, more categories of patients will emerge and treatment will become more personalized.The oncologist was speaking at a convention titled `Controversies […]

Advanced Oncotherapy (AVO) – Exercise of warrants and options and issue of shares

Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it has agreed to issue 7,166,667 new ordinary shares  of 1p in the Company to Dr. Nick Plowman, Chairman of the Medical Advisory Board, pursuant to the exercise of warrants and options at prices between 1.1 pence and 5 pence. […]

Advanced Oncotherapy (AVO) – Exercise of Warrants and issue of Shares

Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it has today issued 34,122,682 new ordinary shares of 1p in the Company at a price of 1.1 pence per New Share pursuant to the exercise of warrants by Brahma AG. The warrants were issued on 25 September 2013 to […]

Advanced Oncotherapy (AVO) – Delivery of additional CCL unit and update on Harley Street

Delivery of additional CCL unit and update on Harley Street In-line for high-power testing  Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that the second Coupled Cavity Linac unit has been manufactured and delivered to the Company’s testing facility in Geneva. The CCL accelerating structures are an essential part of the […]

Advanced Oncotherapy – Proton Radiation Therapy Shows Ongoing Advancements Throughout Past Quarter

From TMCNet Education Technology – Business Wire   Proton Radiation Therapy Shows Ongoing Advancements Throughout Past Quarter. Since physician scientists from Loma Linda University’s Cancer Center (LLUCC) developed and brought proton therapy into the hospital setting 25 years ago, the technology has saved thousands of lives and has shown countless advancements. “Proton therapy’s efficacy as […]

Advanced Oncotherapy – Director Dealing and Award of Options

Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Dr Enrico Vanni, a Non-Executive Director of the Company, had on 14th July purchased 1,000,000 ordinary shares of 1 penny each in the Company at 7.9 pence per Ordinary Share. Following this transaction, Dr Vanni now holds 14,050,000 Ordinary Shares representing 1.02% of […]

Advanced Oncotherapy – Exercise of Warrants and Issue of Shares

Exercise of Warrants and Issue of Shares. Issue of Shares Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it has today issued 600,000 new ordinary shares of 1p in the Company at a subscription price of 8 pence per Ordinary Share to Dr Enrico Vanni, a non-executive director, […]

Advanced Oncotherapy – US cancer treatment centre targets China for proton therapy

US cancer treatment centre targets China for proton therapy In its efforts to attract more international cancer patients to Jacksonville, the University of Florida Health Proton Therapy Institute has held its first-ever symposium in China. Representatives for the institute had a two-week visit to China where they met with health care providers to talk about […]

Advanced Oncotherapy – Holdings in company

Changes to the holding of Mr Alberto Colussi of Brahma AG has resulted in his direct voting shareholding falling from 242,689,600 shares to 27,879,630 voting shares (2.026%) and 214,809,970 shares (15.606%)